ATR’s kinase does not play a major role for ATR–PINK1 interactions, which however, does not rule out the possibility that small molecules that disrupt the interface of both proteins could alter mitochondrial functionality and metabolism, thereby presenting a sound approach for cancer treatment. The gene discussed is ATR; the disease is cancer.